Navigation Links
Boston Scientific Elects David Roux To Its Board of Directors
Date:12/16/2013

NATICK, Mass., Dec. 16, 2013 /PRNewswire/ -- The Board of Directors of Boston Scientific Corporation (NYSE:  BSX) has elected David Roux as a Director.  The appointment of Mr. Roux will fill a vacancy that will result from the Board's decision to increase the number of directors comprising the Board from ten to eleven.  The increase in the number of directors and Mr. Roux's appointment to the Board are both effective January 1, 2014.  

Mr. Roux is a co-founder and Senior Director of Silver Lake, a private equity firm focused on technology investing.  He was formerly Chairman and Chief Executive Officer of Liberate Technologies, Executive Vice President at Oracle Corporation and Senior Vice President at Lotus Development.  Mr. Roux serves on the boards of directors of The National Audubon Society and The Institute for Health Metrics and Evaluation at the University of Washington and the boards of trustees of The Jackson Laboratory and Bowdoin College. Mr. Roux holds an M.B.A. from Harvard Business School and an M. Phil. from King's College, Cambridge University.  He is a graduate of Harvard College.

"I am excited to welcome David to our Board," said Pete Nicholas, Chairman of the Board, Boston Scientific Corporation.  "I am confident that his wealth of experience and impressive background will benefit the company and our shareholders." 

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

Media: 
Denise Kaigler 
508-650-8330 (office)  
Corporate Affairs & Communications 
Boston Scientific Corporation  
denise.kaigler@bsci.com                                            

Investors:
Susie Lisa
508-652-5354 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Therapeutics, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Boston MedTech Advisors Enters Into 50th Engagement with Israeli Life Sciences Companies
3. Boston Engineering Corporation awarded ISO 9001 and ISO 13485 certifications
4. Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific
5. Current Regulatory Expectations Affecting the Validation of Reusable Medical Devices is Subject of Dec. 4th Seminar in Boston
6. Boston Scientific Completes Acquisition Of Bard Electrophysiology
7. Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference
8. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
9. Smith Brothers Cough Drops Wants To Rename Boston "Beardston"
10. Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology
11. Biocartis Presents the Successful use of Idylla[TM] for the Detection of the BRAF Mutation Status in Tumour Samples at the International AACR Congress (American Association for Cancer Research) in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... its executive team as the President of its HealthBI division. McFarland will ... and contact centers. , “Scott is a utility player who balances his ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a ... When we’re born, Nature gives us a full supply of melanin – in the ... lose this natural glare-reducing pigment; however, around the age of thirty, we develop a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the present, Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the ... how medication management services are delivered. Based on industry research and market ...
(Date:9/19/2017)... ... September 19, 2017 , ... Back Pain Centers of ... back pain with a reputable physician in their area, announces the addition of ... as Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... ... 2017 , ... The ISO 9001 standard sets out the requirements for a ... and improve customer satisfaction. ISO 9001:2015 was released in 2015 and certified organizations have ... September 2018. , As described in this white paper , ISO ...
Breaking Medicine News(10 mins):